
What We’re Reading: Pfizer CEO on Approval Timeline; AstraZeneca, Oxford Results Reviewed; Surprise Billing Legislation Hits Snag
Pfizer CEO shares his expectations for its coronavirus disease 2019 (COVID-19) vaccine approval; peer review results are in for AstraZeneca and Oxford University’s COVID-19 vaccine candidate; there are now competing legislative proposals on surprise medical billing protection.
Pfizer Chief Expects Vaccine Approval Soon
With his company’s coronavirus disease 2019 (
More Research Needed on AstraZeneca, Oxford University Vaccine Candidate
The potential vaccine from AstraZeneca and Oxford may have hit a bump in the road, according to
Bipartisan Approval on Hold for Protective Measure Against Surprise Medical Bills
A 2-year effort to arrive at an equitable solution to safeguard against excessive bills for routine medical care is mired in now-competing proposals, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.